Abstract
The purpose of this study was to evaluate the potential ability of magnetic resonance imaging (MRI) for evaluation of myocardial iron deposits. The applied MRI technique has earlier been validated for quantitative determination of the liver iron concentration. The method involves cardiac gating and may, therefore, also be used for simultaneous evaluation of myocardial iron. The tissue signal intensities were measured from spin echo images and the myocardium muscle signal intensity ratio was determined. The SI ratio was converted to tissue iron concentration values based on a modified calibration curve from the liver model. The crucial steps of the method were optimized; i.e. recognition and selection of the myocardial slice for analysis and positioning of the regions of interest (ROIs) within the myocardium and the skeletal muscle. This made the myocardial MRI measurements sufficiently reproducible. We applied this method in 41 multiply transfused patients. Our data demonstrate significant positive linear relationships between different iron store parameters and the MRI-derived myocardial iron concentration, which was significantly related to the serum ferritin concentration (ρ = 0.62.P < 0.0001) and to the MRI-determined liver iron concentration (ρ = 0.36,P = 0.02). The myocardial MRI iron concentrations demonstrated also a significant positive correlation with the number of blood units given (ρ = 0.45,P = 0.005) and the aminotransferase serum concentration (ρ = 0.54,P = 0.0008). Our data represents indirect evidence for the ability of MRI techniques based on myocardium/muscle signal intensity ratio measurements to evaluate myocardial iron overload.
Similar content being viewed by others
References
Buja LM. Roberts WC. Iron in the heart. Am J Med 1971:51:209–21.
Ehlers K. Levin A, Markenson AL, Marcus JL, Klein AA, Hilgartner MW. Englc MA. Longitudinal study of cardiac function in thalassemia major. Ann NY Acad Sci 1980:344:397–404.
Engle MA, Erlandson M. Smith CH. Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis. Circulation 1964:30:689 -705.
Leon MB, Borer JS. Bacharach SL, Green MV. Benz EL Jr. Griffith P, Nienhuis AW. Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload. New Engl J Med 1979:301:1143–8.
Valdes-Cruz L, Reinenke C. Rutkowski M, Dudell GG, Goldberg SJ, Allen HD. Sahn DJ. Piomelli S. Preclinical abnormal segmental cardiac manifestations of thalassemia major in children on transfusion-chelation therapy: Echographic alteration of left ventricular posterior wall contraction and relaxation patterns. Am Heart J 1982:103:505–12.
Cecchetti G. Binda A, Pipcrno A. Nador F, Fargion S, Fiorelli G. Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: Polygraphic and echocardiographic evaluation. Eur Heart J 1991:12:224–9.
Fitchett DH. Coltart DJ, Littler WA. Leyland MJ, Trueman T, Gozzard DI. Peters TJ. Cardiac involvement in secondary haemochromatosis: A catheter biopsy study and analysis of myocardium. Cardiovasc Res 1980:14:719–24.
Barosi G. Arbustini E, Gavazzi A. Grasso M. Pucci A. Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients. Eur J Haematol 1989:42:382–8.
Olson JL, Edwards WD, McCall JT, Ilstrup DM, Gersh BJ. Cardiac iron deposition in idiopathic hemochromatosis: Histologie and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 1987:10:1239–43.
Kaltwasser JP, Gottschalk R, Schalk KP. Hartl W. Non-invasive quantitation of liver iron overload by magnetic resonance imaging. Br J Haematol 1990:74:360–3.
Jensen PD, Jensen FT, Christensen T. Ellegaard J. Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol 1994:87:171–84.
Angelucci E. Giovagnoni A, Valeri G, Paci E. Ripalti M. Muretto P. Mclaren C, Brittenham GM. Lucarelli G. Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood 1997:90:4736–42.
Mavrogeni SI, Gotsis ED, Markussis V, Tsekos N, Politis C. Vretou E, Kremastinos D. T2 relaxation time study of iron overload in b-thalassemia. Vlagn Res Mat Biol Phys Med 1998:6:7–12.
Olivieri NF, Koren G, Matsui D, Liu PP, Blendis L, Cameron R, McClelland RA, Tempelton D. Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral chelator LI in thalassemia intermedia. Blood 1992;79:2741–8.
Chan PCK, Liu P, Cronin C, Heathcote J, Uldall R. The use of magnetic resonance imaging in monitoring the total iron in hemodialysis patients with hemosiderosis treated with erythropoietin and phlebotomy. Am J Kidney Dis 1992; 19:484–9.
Liu P, Henkelman M, Joshi J, Hardy P, Butany J, Iwanochko M, Clauberg M, Dhar M, Mai D, Waien S, Olivieri NF. Quantification of cardiac and tissue iron by nuclear magnetic resonance in a novel m urine thalassemia-cardiac iron overload model. Can J Cardiol 1996; 12:155–64.
Jensen PD, Jensen FT, Christensen T, Ellegaard J. Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients. Br J Haematol 1995:89:880–9.
Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321223.
Brasch RC, Vesbey GE, Gooding CA, Koerper M. Magnetic resonance imaging of transfusional hemosiderosis complicating thlassemia major. Radiology 1984; 150:767–71.
Johnston DL, Rice L, Vick GW, Hedrick TD, Rokey R. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 1989;87:40–7.
Stark DD, Moseley ME, Bacon BR, Moss AA, Goldberg HI, Bass MN, James TL. Magnetic resonance imaging and spectroscopy of hepatic iron. Radiology 1985; 154:137–42.
Ernst O, Sergent G, Bonvarlet P, Canva-Delcambre V, Paris J-C, L’Hermine C. Hepatic iron overload: Diagnosis and quantification with MR imaging. Am J Roentgenol 1997;168:1205–8.
Bonkovsky HL. Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in ironstorage disease. Gastroenterology 1990;99:1079–91.
Jensen PD, Bagger JP, Jensen FT, Baandrup U. Christensen T, Ellegaard J. Heart transplantation in a case of juvenile hereditary haemochromatosis followed up by MRI and endomyocardial biopsies. Eur J Haematol 1993;51:199–205.
Keschner HW. The heart in hemochromatosis. Southern Med J 1951;44:927–31.
Craven CM, Alexander J, Eldridge M, Kushner JP, Bernstein S. Kaplan J. The distribution and clearance kinetiks of non-transferrin-bound iron in the hypo-transferrinemic mouse: a rodent model for hemochromatosis. Proc Natl Acad Sci USA 1987;84:3457–61.
Torrance JD, Bothwell TH. Tissue iron stores. In: Cook JD, editor. Methods in Hematology. New York: Churchill Livingstone, 1980:90–115.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jensen, P.D., Jensen, F.T., Christensen, T. et al. Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload. MAGMA 12, 153–166 (2001). https://doi.org/10.1007/BF02668097
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02668097